Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-04-20Research on Artificial Intelligence-based Mayo Score Recognition System for Disease Activity Degree of Ulcerative Colitis Under Digestive Endoscopy
-
CLINICAL_TRIALS study record update · 2022-04-15Association of Golimumab Trough Levels With Endoscopic and Histologic Healing in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2022-04-14Prevention of Ulcerative Colitis by Prebiotics: Efficacy and Protective Mechanisms
-
CLINICAL_TRIALS study record update · 2022-04-11The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD
-
CLINICAL_TRIALS study record update · 2022-04-06Effect of UGIR on Quality of Life in Adults With Compromised Gut Function and Malabsorption
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-22Electrical Vagal Nerve Stimulation in Ulcerative Colitis - a Double Blind Placebo - Controlled Study of Transcutaneous Vagal Nerve Stimulation in Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2022-03-21A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of BBT-401-1S in Patients With Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2022-03-16Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE-CIHR SPOR Chronic Disease Network
-
CLINICAL_TRIALS study record update · 2022-03-14Pharmacokinetic and Pharmacodynamic Study of Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
-
CLINICAL_TRIALS study record update · 2022-03-10A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Healthy Adult Male and Female Volunteers
-
CLINICAL_TRIALS study record update · 2022-03-09Individualization of Oral Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis: A Pilot Study
-
CLINICAL_TRIALS study record update · 2022-03-04Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery for Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2022-02-28A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
-
CLINICAL_TRIALS study record update · 2022-02-22Fecal Microbial Transplantation in Patients With Medication Refractory Clostridium Difficile and/or Ulcerative Colitis or Indeterminate Colitis
-
CLINICAL_TRIALS study record update · 2022-02-21An Observational, Prospective Cohort Study to Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)
-
CLINICAL_TRIALS study record update · 2022-02-15Establishment of Prediction Model of Biologics and Small Molecular Agent for Patients With Ulcerative Colitis Using Longitudinal Data
-
CLINICAL_TRIALS study record update · 2022-02-15A Clinical Study on the Safety and Effectiveness of Targeting CD7 Chimeric Antigen Receptor T Cells in the Treatment of Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2022-02-01The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients
-
CLINICAL_TRIALS study record update · 2022-01-24An Exploratory, 14-week, Open-label Clinical Food Study to Evaluate the Effects of KB295 in Adult Patients With Ulcerative Colitis (UC) Presenting With Mild-to-moderate UC Symptoms
-
CLINICAL_TRIALS study record update · 2022-01-14A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
-
CLINICAL_TRIALS study record update · 2022-01-13A Phase IIa (Proof of Concept), Randomized, Double Blind, Placebo Controlled, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of Oral Treatment With PBF-677 in Patients With Mild to Moderate Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2022-01-13An International, Prospective, Observational Study of Patients With Chronic Inflammatory Diseases, to Assess 12-months Persistence Drivers After Switching to an Adalimumab Biosimilar, Idacio®, in a Real World Setting
-
CLINICAL_TRIALS study record update · 2022-01-04PhaRmacOkinetics and PHarmacodynamic BiomarkErs of Janus Kinase Inhibitor Therapy in PatIents With Ulcerative Colitis (PROPHETIC)
-
CLINICAL_TRIALS study record update · 2021-12-28A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06687234 AS ADD-ON THERAPY TO INFLIXIMAB IN ACTIVE ULCERATIVE COLITIS SUBJECTS WHO ARE NOT IN REMISSION (BUILD UC)
-
CLINICAL_TRIALS study record update · 2021-12-22Use of a Novel Diet (UC Diet) Targeting the Microbiota for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis: An Open Label Pilot Study